High Mark Wealth Management LLC Centessa Pharmaceuticals PLC Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, High Mark Wealth Management LLC holds 166,135 shares of CNTA stock, worth $2.42 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
166,135
Previous 167,135
0.6%
Holding current value
$2.42 Million
Previous $2.67 Million
4.12%
% of portfolio
1.61%
Previous 1.47%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
116Shares Held
120MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$291 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$145 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$141 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$92.6 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$84.7 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.38B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...